Mojdeh Poul and Kevin Conroy Join Align Technology Board of Directors
05 Dicembre 2023 - 10:01PM
Business Wire
Align Technology, Inc. (NASDAQ: ALGN) today announced that its
Board of Directors has appointed Mojdeh Poul, former EVP and Group
President of 3M Health Care, and Kevin Conroy, President, Chief
Executive Officer, and Chairman of the Board of Exact Sciences.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20231205333071/en/
Image of Mojdeh Poul (Photo: Business
Wire)
“I am pleased to welcome Mojdeh and Kevin to Align’s board of
directors,” said Joe Hogan, president and CEO of Align Technology.
“Each brings extensive experience across the healthcare industry
that complements the depth and breadth of Align’s board. Mojdeh has
led global businesses and operations in large multinational
organizations and has deep expertise in business strategy and
transformation, as well as commercial excellence. Kevin has an
exceptional track-record for growth and his technical and clinical
expertise, combined with a focus on digitally innovative solutions,
have delivered amazing customer experiences. Mojdeh and Kevin are
both outstanding additions to our board and I am confident that
their knowledge and insights will benefit Align as we continue to
drive the evolution of digital orthodontics and restorative
dentistry globally.”
Mojdeh Poul was most recently executive vice president and group
president of 3M Health Care where she was responsible for its
global P&L, strategy, research & development, manufacturing
and commercial operations. During her tenure at 3M, Ms. Poul held
leadership roles, including executive vice president of Safety
& Graphics Business Group, president of 3M Canada, and
president of two divisions within the 3M Health Care Business
Group. Prior to 3M, Ms. Poul held several leadership roles of
increasing responsibility with Medtronic and Boston Scientific, two
leading global medical technology companies. Prior to this, Ms.
Poul held engineering positions with General Electric Plastics. Ms.
Poul currently serves as a director of iRhythm Technologies and
Stanley Black and Decker. Ms. Poul holds a M.B.A. degree from
University of North Carolina, Chapel Hill, and M.Eng. and B.S.
degrees in Mechanical Engineering from the University of
Louisville.
Kevin Conroy is President, Chief Executive Officer, and Chairman
of the Board of Exact Sciences Corporation. He became CEO in 2009
and Chairman in 2014, transforming the organization into one of the
world's premier cancer diagnostics companies. Mr. Conroy led Exact
Sciences through the development and commercialization of its
noninvasive colorectal cancer screening test, Cologuard®, which
became the first medical device or diagnostic to receive
simultaneous FDA approval and national Medicare coverage. Prior to
Exact Sciences, Mr. Conroy served as CEO and president of Third
Wave Technologies, held leadership positions at GE Healthcare, and
practiced intellectual property law in private practice. Mr. Conroy
formerly served as a director of Adaptive Biotechnologies
Corporation, Epizyme, Inc., and SomaLogic, Inc. Mr. Conroy holds a
J.D. degree from University of Michigan Law School and a B.S.E.
degree in Electrical Engineering from Michigan State
University.
Ms. Poul and Mr. Conroy will be included in the company’s slate
of director nominees in the proxy statement for Align’s 2024 Annual
Meeting of Shareholders. Align’s board is comprised of 10
directors, four of whom will have been appointed in the last six
years.
About Align Technology, Inc.
Align Technology designs and manufactures the Invisalign®
System, the most advanced clear aligner system in the world, iTero™
intraoral scanners and services, and exocad™ CAD/CAM software.
These technology building blocks enable enhanced digital
orthodontic and restorative workflows to improve patient outcomes
and practice efficiencies for over 252 thousand doctor customers
and is key to accessing Align’s 600 million consumer market
opportunity worldwide. Over the past 26 years, Align has helped
doctors treat 16.4 million patients with the Invisalign System and
is driving the evolution in digital dentistry through the Align
Digital Platform™, our integrated suite of unique, proprietary
technologies and services delivered as a seamless, end-to-end
solution for patients and consumers, orthodontists and GP dentists,
and lab/partners. Visit www.aligntech.com for more information.
For additional information about the Invisalign system or to
find an Invisalign doctor in your area, please visit
www.invisalign.com. For additional information about the iTero
digital scanning system, please visit www.itero.com. For additional
information about exocad dental CAD/CAM offerings and a list of
exocad reseller partners, please visit www.exocad.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231205333071/en/
Align Technology Madelyn Valente
(909) 833-5839 mvalente@aligntech.com
Zeno Group Sarah Johnson (828)
551-4201 sarah.johnson@zenogroup.com
Grafico Azioni Align Technology (NASDAQ:ALGN)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Align Technology (NASDAQ:ALGN)
Storico
Da Giu 2023 a Giu 2024